Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

Selim Corbacioglu(Unknown), Giorgio Dini, Karoline Ehlert(Universitätsmedizin Greifswald), Susanne Matthes‐Martin(St Anna Children's Hospital), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences), Ingo Müller(Universität Hamburg), Dominique Valteau‐Couanet(Institut Gustave Roussy), Jerry Stein(Schneider Children's Medical Center), Simone Cesaro(Azienda Ospedaliera Universitaria Integrata Verona), Ansgar Schulz(University Hospital Ulm), Bernd Gruhn(Jena University Hospital), Attilio Rovelli(Azienda Ospedaliera San Gerardo), Jacek Winiarski(Karolinska University Hospital), Monika Führer, Ralph B. D’Agostino(Wake Forest University), Peter Bader(Goethe University Frankfurt), Johanna Schrum(Universität Hamburg), Jaap Jan Boelens(Wilhelmina Children's Hospital), Maura Faraci(Istituto Giannina Gaslini), Margaret Hoyle(The Fertilizer Institute), André Schrauder(University Hospital Schleswig-Holstein), Annette Hewitt(Great Ormond Street Hospital), Jacek Toporski(Skåne University Hospital), Klaus‐Michael Debatin(German Centre for Cardiovascular Research), Johann Greil(German Center for Pediatric and Adolescent Rheumatology), Anders Fasth(University of Gothenburg), Massimo Iacobelli(Figli Adottivi e Genitori Naturali), Robert Wynn(Royal Manchester Children's Hospital), Anne O’Meara(Our Lady's Hospital), Petr Sedláček(University Hospital in Motol), Paul G. Schlegel(Goethe University Frankfurt), Karl-Walter Sykora(Medizinische Hochschule Hannover), Johan Arvidson(Uppsala University Hospital), Christine Mauz‐Körholz(Justus-Liebig-Universität Gießen), Joseph M. Massaro(Boston University)
The Lancet
February 22, 2012
Cited by 376


Related Papers